Acinetobacter baumannii (A. baumannii) is undoubtedly one of the most successful
pathogens in the modern healthcare system. With invasive procedures, antibiotic use and …

Amid the recent attention focused on the growing impact of methicillin-resistant
Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa infections, the …

Antimicrobial resistance (AMR) represents a major challenge to global health. This problem
is most apparent in healthcare facilities, with a comparatively small number of pathogens …

Acinetobacter baumannii is a problematic pathogen of global concern. It causes multiple
types of infection, especially among immunocompromised individuals in intensive care units …

Acinetobacter baumannii is an opportunistic pathogen which is undoubtedly known for a
high rate of morbidity and mortality in hospital-acquired infections. A. baumannii causes life …

Acinetobacter baumannii is an emerging pathogen, and over the last three decades it has
proven to be particularly difficult to treat by healthcare services. It is now regarded as a …

Multidrug-resistant (MDR) Acinetobacter baumannii (A. baumannii) bacterium, a nosocomial
pathogen associated with a high mortality rate and limited therapeutic options have …

Background Multidrug resistance in Acinetobacter baumannii is constantly on the rise. There
has also been an increase in the morbidity and mortality of patients with infection by the …

Comprehensive data on drug‐resistant patterns of Acinetobacter baumannii isolates in
developing countries is limited. We conducted a multihospital study to assess the rate and …

Acinetobacter baumannii (AB) is one of the most notorious and opportunistic pathogens,
which caused high morbidity and mortality rate and World Health Organization (WHO) …